2009
DOI: 10.1136/gut.2008.167957
|View full text |Cite
|
Sign up to set email alerts
|

Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease

Abstract: Objective: Assessment of disease extension and activity is crucial to guide treatment in Crohn's disease. The objective of the current cross-sectional study was to determine the accuracy of MR for this assessment. Design: 50 patients with clinically active (n = 35) or inactive (n = 15) Crohn's disease underwent ileocolonoscopy (reference standard) and MR. T2-weighted and precontrast and postcontrast-enhanced T1-weighted sequences were acquired. Endoscopic activity was evaluated by CDEIS (Crohn's Disease Endosc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

10
541
4
15

Year Published

2010
2010
2017
2017

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 602 publications
(570 citation statements)
references
References 36 publications
(43 reference statements)
10
541
4
15
Order By: Relevance
“…Recently, a radiological index of disease activity, the Magnetic Resonance Index of Activity (MRIA), has been described based on the quantitative changes observed on MRE. This correlates with the severity of the endoscopic lesions and with the presence of oedema, ulcers, size of lymph nodes and the presence of pseudopolyps (14,15). In our series, we evaluate CD activity based on wall thickening, the presence of ulcers, increase in vascularisation, mesenteric inflammation and the presence of reactive lymphadenopathies (16).…”
Section: Discussionmentioning
confidence: 99%
“…Recently, a radiological index of disease activity, the Magnetic Resonance Index of Activity (MRIA), has been described based on the quantitative changes observed on MRE. This correlates with the severity of the endoscopic lesions and with the presence of oedema, ulcers, size of lymph nodes and the presence of pseudopolyps (14,15). In our series, we evaluate CD activity based on wall thickening, the presence of ulcers, increase in vascularisation, mesenteric inflammation and the presence of reactive lymphadenopathies (16).…”
Section: Discussionmentioning
confidence: 99%
“…9/13 patients who completed PET scanning both at baseline and a median [range] of 12 [11][12][13][14][15][16][17][18] weeks after initiation of anti-TNF treatment had favourable clinical responses 27 (median [range] responder ΔHBI = 5 [3][4][5][6][7][8][9]; non-responder ΔHBI = 1[-1-2]), (Table 1). …”
Section: Contrasting Fdg-pet Measures In Responders Versus Non-responmentioning
confidence: 99%
“…Table 6 4 Test-retest repeatability 5 patients (1 female) with active CD were recruited for this arm of the study, and 4 completed the two scans within a median [range] period of 7 [4][5][6][7][8][9][10][11][12] days. The repeatability of the PET measures were estimated in segments with a signal focus > LivSUVMEAN (Table 7).…”
Section: Responsiveness Ratiosmentioning
confidence: 99%
See 1 more Smart Citation
“…However, there are still many registration problems that remain challenging. We encountered such a challenge upon registering three-dimensional pre-to post-contrast abdominal images acquired by magnetic resonance imaging (MRI) for quantifying Crohn's disease activity [1]. This registration is far from trivial as peristalsis of the bowel (or organ motion) may cause large local deformations, which makes that the registration algorithm gets trapped in a local minimum as discussed in [2].…”
Section: Introductionmentioning
confidence: 99%